Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Dl-amphetamine Sulfate
2. Amphetamine Sulphate
3. Phenaminum
4. 60-13-9
5. Amphamine Sulfate
6. Amphetamini Sulfas
7. Dl-phenamine Sulfate
8. Dl-amphetamine Sulphate
9. Amphetaminium Sulfuricum
10. Desoxynorephedrine Sulfate
11. (+-)-amphetamine Sulfate
12. Dl-amphetamine Hydrogen Sulfate
13. (+-)-phenisopropylamine Sulfate
14. Amfetamine Sulfate
15. Amphetamine Sulfate [usp]
16. Dl-1-phenyl-2-aminopropane Sulfate
17. (+-)-2-amino-1-phenylpropane Sulfate
18. (+-)-alpha-methylphenethylamine Sulfate (2:1)
19. 6dpv8nk46s
20. 1-phenylpropan-2-amine Sulfate (2:1)
21. Amphetamine Sulfate (usp)
22. Fenopromin Sulfate
23. Penamine (van)
24. Ccris 3644
25. 1-phenyl-2-aminopropane Sulfate
26. Cerm 1767
27. Razemisches Phenylaminopropansulfat
28. Dl-alpha-methylphenethylamine Sulfate
29. Einecs 200-457-8
30. Unii-6dpv8nk46s
31. Nsc 170999
32. Dl-amphetamine Sulfate Salt
33. Benzadrine
34. Alpha-methylphenethylamine Sulfate, (+-)-
35. Benzedrine (tn)
36. Evekeo (tn)
37. Evekeo Odt
38. Rac-amphetamine Sulphate
39. D-amphetamine Sulfate Salt
40. Schembl41204
41. Amphetamine Sulfate [mi]
42. Dtxsid4020082
43. Phenethylamine, Alpha-methyl-, Sulfate (2:1), (+-)-
44. Chebi:51063
45. Amfetamine Sulfate [mart.]
46. Amphetamine Sulfate [vandf]
47. Amfetamine Sulfate [who-dd]
48. Bis{1-phenylpropan-2-amine} Sulfate
49. Amfetamine Sulfate [ep Impurity]
50. Amfetamine Sulfate [ep Monograph]
51. Amphetamine Sulfate [orange Book]
52. .beta.-phenylisopyropylaminesulfate
53. Benzeneethanamine, Alpha-methyl-, Sulfate
54. Amphetamine Sulfate [usp Monograph]
55. Amfetamine Sulfate [incb:green List]
56. Delcobese Component Amphetamine Sulfate
57. D02074
58. (+/-)-2-amino-1-phenylpropane Sulfate
59. (+/-)-2-amino-1-phenylpropane Sulphate
60. Amphetamine Sulfate Component Of Delcobese
61. Q21270844
62. (+/-)-.alpha.-methylphenethylamine Sulfate (2:1)
63. (+/-)-.alpha.-methylphenethylamine Sulphate (2:1)
64. Benzeneethanamine, .alpha.-methyl-, Sulfate (2:1), (+/-)-
65. Benzeneethanamine, .alpha.-methyl-, Sulphate (2:1), (+/-)-
66. Dl-amphetamine Sulfate Salt Solution, Drug Standard, 1.0 Mg/ml In Methanol
67. 2-(tetrahydro-furan-2-yl)-n-(3-trifluoromethyl-phenyl)-succinamicacid
68. 156-31-0
1. Amfetamine
2. Mydrial
3. Desoxynorephedrine
4. L Amphetamine
| Molecular Weight | 368.5 g/mol |
|---|---|
| Molecular Formula | C18H28N2O4S |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | 368.17697855 g/mol |
| Monoisotopic Mass | 368.17697855 g/mol |
| Topological Polar Surface Area | 135 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 166 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-01-03
Pay. Date : 2013-11-21
DMF Number : 16019
Submission : 2002-06-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14783
Submission : 2000-03-17
Status : Active
Type : II
NDC Package Code : 49812-0058
Start Marketing Date : 1999-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
| Available Reg Filing : CA |
Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Siegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-08-04
Pay. Date : 2015-08-27
DMF Number : 29601
Submission : 2016-02-25
Status : Active
Type : II
NDC Package Code : 0792-3939
Start Marketing Date : 2023-11-22
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-01-03
Pay. Date : 2013-11-21
DMF Number : 16021
Submission : 2002-06-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15089
Submission : 2000-10-13
Status : Active
Type : II
NDC Package Code : 49812-0059
Start Marketing Date : 1999-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
| Available Reg Filing : CA |
Siegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-05-24
Pay. Date : 2015-08-27
DMF Number : 29604
Submission : 2016-02-25
Status : Active
Type : II
NDC Package Code : 0792-3936
Start Marketing Date : 2022-12-02
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-03
Pay. Date : 2013-11-21
DMF Number : 16019
Submission : 2002-06-21
Status : Active
Type : II
Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-03
Pay. Date : 2013-11-21
DMF Number : 16021
Submission : 2002-06-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14783
Submission : 2000-03-17
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-04-10
Pay. Date : 2013-04-03
DMF Number : 24048
Submission : 2010-07-08
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-04-10
Pay. Date : 2013-04-03
DMF Number : 23583
Submission : 2010-03-04
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15089
Submission : 2000-10-13
Status : Active
Type : II
Siegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.
GDUFA
DMF Review : Complete
Rev. Date : 2023-11-22
Pay. Date : 2023-11-03
DMF Number : 38836
Submission : 2023-10-20
Status : Active
Type : II
Siegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.
GDUFA
DMF Review : Complete
Rev. Date : 2016-05-24
Pay. Date : 2015-08-27
DMF Number : 29604
Submission : 2016-02-25
Status : Active
Type : II
Siegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.
GDUFA
DMF Review : Complete
Rev. Date : 2016-08-04
Pay. Date : 2015-08-27
DMF Number : 29601
Submission : 2016-02-25
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R0-CEP 2021-478 - Rev 00
Status : Valid
Issue Date : 2023-06-15
Type : Chemical
Substance Number : 2752

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2019-097 - Rev 01
Status : Valid
Issue Date : 2025-01-03
Type : Chemical
Substance Number : 2752

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R0-CEP 2020-076 - Rev 00
Status : Valid
Issue Date : 2021-07-26
Type : Chemical
Substance Number : 2752

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC Package Code : 49812-0058
Start Marketing Date : 1999-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49812-0059
Start Marketing Date : 1999-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Siegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.
NDC Package Code : 0792-3936
Start Marketing Date : 2022-12-02
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Siegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.
NDC Package Code : 0792-3939
Start Marketing Date : 2023-11-22
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-1971
Start Marketing Date : 2012-10-26
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 59116-1941
Start Marketing Date : 2012-10-26
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 61960-0210
Start Marketing Date : 2016-10-21
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 0406-9451
Start Marketing Date : 2025-08-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 0406-1950
Start Marketing Date : 2013-04-29
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 65392-0110
Start Marketing Date : 2018-04-24
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
About the Company : Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners tur...
About the Company : Veranova is a global leader in developing and manufacturing specialist and complex APIs for pharma and biotech customers, with over 50 years of experience supporting the healthcare...
Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
About the Company : Malladi Drugs & Pharmaceuticals Ltd, founded in 1980 by Mr. M L N Sastry, is a leader in manufacturing ephedrine and pseudoephedrine salts. It is now the top API manufacturer in th...
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
About the Company : Supriya Lifescience Limited, established in 1987 and headquartered in Mumbai, is a globally recognized, technology-driven manufacturer of APIs, CDMO, and formulations. Its faciliti...
Siegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.
About the Company : Siegfried is a global Contract Development and Manufacturing Organization providing integrated services for pharmaceutical ingredients & finished dosage forms. With 13 production s...
About the Company : Axyntis Group, founded in 2007, is France’s leading independent multi-site player in fine chemicals with a €90 million annual turnover. Axyntis has become a key producer of API...

About the Company : Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years...

About the Company : Chr. Olesen Synthesis is a Danish manufacturer of APIs and advanced intermediates. Chr. Olesen Synthesis was established in 2012 after the Chr. Olesen Group acquisition of the mult...

About the Company : We have been supporting the pharmaceutical and biopharmaceutical industries with drug development for over 30 years, assisting our clients in developing and bringing new drugs to m...

About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to addr...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Amphetamine Sulfate, a controlled substance targeting Norepinephrine and Dopamine transporters, shows promise in treating Attention Deficit Hyperactivity Disorder (ADHD).
Lead Product(s): Amphetamine Sulfate,Inapplicable
Therapeutic Area: Psychiatry/Psychology Brand Name: Dyanavel-Generic
Study Phase: Approved FDFProduct Type: Controlled Substance
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 08, 2026
Lead Product(s) : Amphetamine Sulfate,Inapplicable
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Granules India Receives USFDA Tentative Nod for Generic ADHD Tablets
Details : Amphetamine Sulfate, a controlled substance targeting Norepinephrine and Dopamine transporters, shows promise in treating Attention Deficit Hyperactivity Disorder (ADHD).
Product Name : Dyanavel-Generic
Product Type : Controlled Substance
Upfront Cash : Inapplicable
January 08, 2026
Details:
Amphetamine Sulfate, a small molecule product targeting Norepinephrine and Dopamine transporters, shows promise in treating Attention Deficit Hyperactivity Disorder.
Lead Product(s): Amphetamine Sulfate,Inapplicable
Therapeutic Area: Psychiatry/Psychology Brand Name: Adzenys XR-ODT-Generic
Study Phase: Approved FDFProduct Type: Controlled Substance
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable December 22, 2025
Lead Product(s) : Amphetamine Sulfate,Inapplicable
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Granules Pharma Gets USFDA Tentative Approval for Amphetamine ER ODT ANDA
Details : Amphetamine Sulfate, a small molecule product targeting Norepinephrine and Dopamine transporters, shows promise in treating Attention Deficit Hyperactivity Disorder.
Product Name : Adzenys XR-ODT-Generic
Product Type : Controlled Substance
Upfront Cash : Inapplicable
December 22, 2025
Details:
Dextroamphetamine Sulfate is a non-catecholamine sympathomimetic amines with CNS stimulant activity. It is thought to block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extraneuronal space.
Lead Product(s): Amphetamine Sulfate,Amphetamine Aspartate,Dextroamphetamine Saccharate
Therapeutic Area: Psychiatry/Psychology Brand Name: Amphetamine-Generic
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 24, 2023
Lead Product(s) : Amphetamine Sulfate,Amphetamine Aspartate,Dextroamphetamine Saccharate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Granules Pharmaceuticals Inc., Receives ANDA Approval for Amphetamine Mixed Salts ER Capsules
Details : Dextroamphetamine Sulfate is a non-catecholamine sympathomimetic amines with CNS stimulant activity. It is thought to block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extr...
Product Name : Amphetamine-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 24, 2023
Details:
FDA approved generic of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, for Attention Deficit Hyperactivity Disorder and Narcolepsy.
Lead Product(s): Dextroamphetamine Saccharate,Amphetamine Aspartate,Amphetamine Sulfate
Therapeutic Area: Psychiatry/Psychology Brand Name: Adderall-Generic
Study Phase: Approved FDFProduct Type: Controlled Substance
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable December 30, 2021
Lead Product(s) : Dextroamphetamine Saccharate,Amphetamine Aspartate,Amphetamine Sulfate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Granules Pharmaceuticals Receives ANDA Approval for Amphetamine Mixed Salts (IR Tablets)
Details : FDA approved generic of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, for Attention Deficit Hyperactivity Disorder and Narcolepsy.
Product Name : Adderall-Generic
Product Type : Controlled Substance
Upfront Cash : Inapplicable
December 30, 2021
Details:
Amphetamine Sulfate is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Attention Deficit Disorder with Hyperactivity.
Lead Product(s): Amphetamine Sulfate,Inapplicable
Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Miscellaneous
Sponsor: Premier Research Group
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 11, 2025

Lead Product(s) : Amphetamine Sulfate,Inapplicable
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Premier Research Group
Deal Size : Inapplicable
Deal Type : Inapplicable
ADZENYS XR-ODT™ in Children (4 to <6 Years) Diagnosed With Attention-deficit/Hyperactivity Disor...
Details : Amphetamine Sulfate is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Attention Deficit Disorder with Hyperactivity.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 11, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Through the acquisition of Amphetamine Sulfate, a controlled substance targeting Norepinephrine transporter and Dopamine transporter, the deal aims to advance neuroscience research.
Lead Product(s): Amphetamine Sulfate,Inapplicable
Therapeutic Area: Psychiatry/Psychology Brand Name: Evekeo-Generic
Study Phase: Approved FDFProduct Type: Controlled Substance
Sponsor: Aurobindo Pharma Limited
Deal Size: $250.0 million Upfront Cash: Undisclosed
Deal Type: Acquisition July 31, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Amphetamine Sulfate,Inapplicable
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Aurobindo Pharma Limited
Deal Size : $250.0 million
Deal Type : Acquisition
Aurobindo to Acquire Lannett for Rs. 2,185 Cr
Details : Through the acquisition of Amphetamine Sulfate, a controlled substance targeting Norepinephrine transporter and Dopamine transporter, the deal aims to advance neuroscience research.
Product Name : Evekeo-Generic
Product Type : Controlled Substance
Upfront Cash : Undisclosed
July 31, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Adderall-Generic is a CNS stimulant, which is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and Narcolepsy.
Lead Product(s): Dextroamphetamine Saccharate,Amphetamine Aspartate,Amphetamine Sulfate,Dextroamphetamine Sulphate
Therapeutic Area: Psychiatry/Psychology Brand Name: Adderall-Generic
Study Phase: Approved FDFProduct Type: Controlled Substance
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable April 17, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Dextroamphetamine Saccharate,Amphetamine Aspartate,Amphetamine Sulfate,Dextroamphetamine Sulphate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Glenmark to Launch Generic Version of Adderall Tablets in the US Market by May 2025
Details : Adderall-Generic is a CNS stimulant, which is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and Narcolepsy.
Product Name : Adderall-Generic
Product Type : Controlled Substance
Upfront Cash : Inapplicable
April 17, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Adderall XR-Generic is a combination product of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate & amphetamine sulfate. It is indicated for ADHD.
Lead Product(s): Dextroamphetamine Saccharate,Amphetamine Aspartate,Amphetamine Sulfate
Therapeutic Area: Psychiatry/Psychology Brand Name: Adderall XR-Generic
Study Phase: Approved FDFProduct Type: Controlled Substance
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable November 21, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Dextroamphetamine Saccharate,Amphetamine Aspartate,Amphetamine Sulfate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lupin Receives FDA Approval for Generic Version of Adderall XR
Details : Adderall XR-Generic is a combination product of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate & amphetamine sulfate. It is indicated for ADHD.
Product Name : Adderall XR-Generic
Product Type : Controlled Substance
Upfront Cash : Inapplicable
November 21, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
The agreement aims for the distribution and supply for Aytu's Adzenys XR-ODT and Cotempla XR-ODT product lines for the treatment of ADHD in Canada.
Lead Product(s): Amphetamine Sulfate,Inapplicable
Therapeutic Area: Psychiatry/Psychology Brand Name: Adzenys XR-ODT
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Lupin Pharma Canada
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement October 01, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Amphetamine Sulfate,Inapplicable
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Lupin Pharma Canada
Deal Size : Undisclosed
Deal Type : Agreement
Aytu BioPharma Partners with Lupin Canada For ADHD Drug Commercialization
Details : The agreement aims for the distribution and supply for Aytu's Adzenys XR-ODT and Cotempla XR-ODT product lines for the treatment of ADHD in Canada.
Product Name : Adzenys XR-ODT
Product Type : Miscellaneous
Upfront Cash : Undisclosed
October 01, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Tris Pharma and Perigon launched a direct-to-patient program, that allows patients and caregivers access to DYANAVEL XR (amphetamine) extended-release tablets through Perigon’s digital pharmacy and receive assistance and support to help navigate their treatment journey.
Lead Product(s): Amphetamine Sulfate,Inapplicable
Therapeutic Area: Psychiatry/Psychology Brand Name: Dyanavel XR
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Perigon Pharmacy 360
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership October 30, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Amphetamine Sulfate,Inapplicable
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Perigon Pharmacy 360
Deal Size : Undisclosed
Deal Type : Partnership
Tris Pharma Partners with Perigon Pharmacy 360 to Enhance Access to DYANAVEL® XR Tablets for the ...
Details : Tris Pharma and Perigon launched a direct-to-patient program, that allows patients and caregivers access to DYANAVEL XR (amphetamine) extended-release tablets through Perigon’s digital pharmacy and receive assistance and support to help navigate their ...
Product Name : Dyanavel XR
Product Type : Miscellaneous
Upfront Cash : Undisclosed
October 30, 2023

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]dl-1-Chloro-1-phenyl-2-aminopropane Hydrochloride
CAS Number : 25394-33-6
End Use API : Amphetamine Sulfate
About The Company : Malladi Drugs & Pharmaceuticals Ltd, founded in 1980 by Mr. M L N Sastry, is a leader in manufacturing ephedrine and pseudoephedrine salts. It is now the top AP...
CAS Number : 3182-95-4
End Use API : Amphetamine Sulfate
About The Company : PMC Isochem, acquired by PMC International in 2017, is a CDMO manufacturing cGMP intermediates, APIs, and functional excipients for global pharmaceutical and pe...
Phenyl Acetone OR 1-Phenyl-2-Peopanone
CAS Number : 103-79-7
End Use API : Amphetamine Sulfate
About The Company : Maisuriya Pharma Solutions is a research-driven & technology-oriented company. Continuous innovations & improvement are the lifeblood of our business. Our major...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
Brand Name : AMPHETAMINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Approval Date : 2020-07-14
Application Number : 213898
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
Brand Name : AMPHETAMINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Approval Date : 2020-07-14
Application Number : 213898
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Approval Date : 1999-05-13
Application Number : 40299
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG
Approval Date : 2019-06-21
Application Number : 205077
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Approval Date : 2019-06-21
Application Number : 205077
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 15MG
Approval Date : 2019-06-21
Application Number : 205077
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG
Approval Date : 2017-10-31
Application Number : 205673
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Approval Date : 2017-10-31
Application Number : 205673
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 15MG
Approval Date : 2017-10-31
Application Number : 205673
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
RLD : No
TE Code : AB1
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Brand Name : DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG;5MG;5MG;5MG
Approval Date : 2023-01-23
Application Number : 217027
RX/OTC/DISCN : RX
RLD : No
TE Code : AB1
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Attention
Dosage Form : Tablet
Dosage Strength : 20mg
Packaging :
Approval Date : 13-02-2019
Application Number : 2.02E+13
Regulatory Info : Deregistered
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Estonia
Brand Name : Tentin
Dosage Form : Tablet
Dosage Strength : 5mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Prescription
Registration Country : Estonia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Tentin
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date : 19-08-2024
Application Number : 89601
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Attention
Dosage Form : Tablet
Dosage Strength : 5mg
Packaging :
Approval Date : 03-10-2014
Application Number : 2.01E+13
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Attention
Dosage Form : Tablet
Dosage Strength : 20mg
Packaging :
Approval Date : 27-06-2018
Application Number : 2.02E+13
Regulatory Info : Deregistered
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Dexfarm
Dosage Form : Tablet
Dosage Strength : 10mg
Packaging :
Approval Date : 13-05-2024
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Dexfarm
Dosage Form : Tablet
Dosage Strength : 20mg
Packaging :
Approval Date : 13-05-2024
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Attentin
Dosage Form : Tablet
Dosage Strength : 10mg
Packaging :
Approval Date : 16/11/2020
Application Number : 67475
Regulatory Info : Allowed
Registration Country : Switzerland

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorised
Registration Country : Malta
Brand Name : Dexamfetamine Sulfate Atnahs
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date : 2019-02-18
Application Number :
Regulatory Info : Authorised
Registration Country : Malta

Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Dexatin
Dosage Form : Tablet
Dosage Strength : 5mg
Packaging :
Approval Date : 12-06-2023
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada
Brand Name : APO-AMPHETAMINE XR
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 5MG
Packaging : 100
Approval Date :
Application Number : 2445492
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada
Brand Name : APO-AMPHETAMINE XR
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 20MG
Packaging : 100
Approval Date :
Application Number : 2445522
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada
Brand Name : DEXEDRINE
Dosage Form : TABLET
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 1924516
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada
Brand Name : SANDOZ AMPHETAMINE XR
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 10MG
Packaging : 100
Approval Date :
Application Number : 2457296
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada
Brand Name : SANDOZ AMPHETAMINE XR
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 20MG
Packaging : 100
Approval Date :
Application Number : 2457326
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada
Brand Name : SANDOZ AMPHETAMINE XR
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 25MG
Packaging : 100
Approval Date :
Application Number : 2457334
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada
Brand Name : ADDERALL XR
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 30MG
Packaging : 100
Approval Date :
Application Number : 2248813
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada
Brand Name : TEVA-AMPHETAMINE XR
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 10MG
Packaging : 100
Approval Date :
Application Number : 2439247
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada
Brand Name : TEVA-AMPHETAMINE XR
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 25MG
Packaging : 100
Approval Date :
Application Number : 2439271
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada
Brand Name : TEVA-AMPHETAMINE XR
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 30MG
Packaging : 100
Approval Date :
Application Number : 2439298
Regulatory Info : CONTROLLED DRUGS (CDSA I)
Registration Country : Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Australia
Brand Name : Aspen Pharmacare Australia Pty Ltd
Dosage Form :
Dosage Strength :
Packaging : 100
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Regulatory Info :
Registration Country : India
Brand Name : Dextroamphetamine Sulf...
Dosage Form : Extended-Release Capsu...
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Extended-Release Capsu...
Dosage Strength : 5MG
Brand Name : Dextroamphetamine Sulf...
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Dextroamphetamine Sulf...
Dosage Form : Extended-Release Capsu...
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Extended-Release Capsu...
Dosage Strength : 10MG
Brand Name : Dextroamphetamine Sulf...
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Dextroamphetamine Sulf...
Dosage Form : Extended-Release Capsu...
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Extended-Release Capsu...
Dosage Strength : 15MG
Brand Name : Dextroamphetamine Sulf...
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Dextroamphetamine Sulf...
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 5MG
Brand Name : Dextroamphetamine Sulf...
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Amphetamine Sulphate
Dosage Form : Immediate Release Tabl...
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Immediate Release Tabl...
Dosage Strength : 10MG
Brand Name : Amphetamine Sulphate
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Mixed Amphetamines
Dosage Form : Extended Release Capsu...
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Extended Release Capsu...
Dosage Strength : 15MG
Brand Name : Mixed Amphetamines
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Mixed Amphetamines
Dosage Form : Extended Release Capsu...
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Extended Release Capsu...
Dosage Strength : 25MG
Brand Name : Mixed Amphetamines
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Mixed Amphetamines
Dosage Form : Extended Release Capsu...
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Extended Release Capsu...
Dosage Strength : 30MG
Brand Name : Mixed Amphetamines
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Mixed Amphetamines
Dosage Form : Immediate Release Tabl...
Dosage Strength : 7.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Immediate Release Tabl...
Dosage Strength : 7.5MG
Brand Name : Mixed Amphetamines
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Mixed Amphetamines
Dosage Form : Immediate Release Tabl...
Dosage Strength : 12.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Immediate Release Tabl...
Dosage Strength : 12.5MG
Brand Name : Mixed Amphetamines
Approval Date :
Application Number :
Registration Country : India
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Dosage Form : Cream / Lotion / Ointment
Grade : Topical, Parenteral
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
https://www.pharmacompass.com/radio-compass-blog/dmf-filings-rise-4-5-in-q3-2025-china-holds-lead-india-records-20-growth-in-submissions
Global Sales Information
Market Place
Reply
25 Nov 2025
Reply
21 Nov 2025
Reply
30 Apr 2025
Reply
19 Jul 2024
Reply
18 Apr 2024
Reply
30 May 2023
Reply
23 Sep 2022
Reply
30 Sep 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Reply
20 Jun 2024

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Patents & EXCLUSIVITIES
Patent Expiration Date : 2026-04-09
US Patent Number : 8840924
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204326
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-04-09

Patent Expiration Date : 2033-10-24
US Patent Number : 9474722
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215401
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-10-24

Patent Expiration Date : 2033-10-24
US Patent Number : 9474722
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215401
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-10-24

Patent Expiration Date : 2042-01-06
US Patent Number : 11559501
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215401
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2042-01-06

Patent Expiration Date : 2033-10-24
US Patent Number : 9456993
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215401
Patent Use Code : U-3340
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-10-24

Patent Expiration Date : 2026-05-12
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
US Patent Number : 9173857
Drug Substance Claim :
Drug Product Claim :
Application Number : 22063
Patent Use Code : U-2025
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-05-12

Patent Expiration Date : 2029-08-24
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
US Patent Number : 8846100
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22063
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-08-24

Patent Expiration Date : 2027-03-15
AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
US Patent Number : 8747902
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208147
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-03-15

Patent Expiration Date : 2027-03-15
AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
US Patent Number : 8597684
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208147
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-03-15

Patent Expiration Date : 2040-02-11
AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
US Patent Number : 12458592
Drug Substance Claim :
Drug Product Claim :
Application Number : 210526
Patent Use Code : U-3538
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2040-02-11

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
CAS Number : 22148-75-0
Quantity Per Vial :
Sale Unit :
Price :
Details : N-formylamphetamine
Monograph : 51634-2040
Storage :
Code/Batch No :
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
CAS Number : 60-13-9
Quantity Per Vial :
Sale Unit :
Price :
Details : USP Impurity
Monograph : 51634-2024
Storage :
Code/Batch No :
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
Dextroamphetamine Sulfate (CII)
CAS Number : 51-63-8
Quantity Per Vial :
Sale Unit :
Price :
Details : USP Impurity
Monograph : 51634-2022
Storage :
Code/Batch No :
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
Dextroamphetamine Sulfate, < 98% EE (CII)
CAS Number : 51-63-8
Quantity Per Vial :
Sale Unit :
Price :
Details :
Monograph : 51634-2022
Storage :
Code/Batch No :
CAS Number :
Quantity Per Vial :
Sale Unit :
Price :
Details :
Monograph :
Storage :
Code/Batch No : 730

Dextroamphetamine Related Compound A (25 mg) ...
CAS Number : 698-87-3
Quantity Per Vial : 25
Sale Unit : mg
Price : $775.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1180015 / F0H131

Dextroamphetamine Related Compound B CII (25 ...
CAS Number : 103-79-7
Quantity Per Vial : 25
Sale Unit : mg
Price : $775.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1180026 / R097P0

Dextroamphetamine Sulfate CII (500 mg)
CAS Number : 51-63-8
Quantity Per Vial : 500
Sale Unit : mg
Price : $340.00
Details : Material Origin- Chemical Synthesis; USMCA- Y...
Monograph :
Storage :
Code/Batch No : Catalog #1180004 / R102M0

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
54
PharmaCompass offers a list of Amphetamine Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amphetamine Sulfate manufacturer or Amphetamine Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amphetamine Sulfate manufacturer or Amphetamine Sulfate supplier.
PharmaCompass also assists you with knowing the Amphetamine Sulfate API Price utilized in the formulation of products. Amphetamine Sulfate API Price is not always fixed or binding as the Amphetamine Sulfate Price is obtained through a variety of data sources. The Amphetamine Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 1-Phenyl-2-aminopropane sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1-Phenyl-2-aminopropane sulfate, including repackagers and relabelers. The FDA regulates 1-Phenyl-2-aminopropane sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1-Phenyl-2-aminopropane sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 1-Phenyl-2-aminopropane sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 1-Phenyl-2-aminopropane sulfate supplier is an individual or a company that provides 1-Phenyl-2-aminopropane sulfate active pharmaceutical ingredient (API) or 1-Phenyl-2-aminopropane sulfate finished formulations upon request. The 1-Phenyl-2-aminopropane sulfate suppliers may include 1-Phenyl-2-aminopropane sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of 1-Phenyl-2-aminopropane sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 1-Phenyl-2-aminopropane sulfate DMF (Drug Master File) is a document detailing the whole manufacturing process of 1-Phenyl-2-aminopropane sulfate active pharmaceutical ingredient (API) in detail. Different forms of 1-Phenyl-2-aminopropane sulfate DMFs exist exist since differing nations have different regulations, such as 1-Phenyl-2-aminopropane sulfate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 1-Phenyl-2-aminopropane sulfate DMF submitted to regulatory agencies in the US is known as a USDMF. 1-Phenyl-2-aminopropane sulfate USDMF includes data on 1-Phenyl-2-aminopropane sulfate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 1-Phenyl-2-aminopropane sulfate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 1-Phenyl-2-aminopropane sulfate suppliers with USDMF on PharmaCompass.
A 1-Phenyl-2-aminopropane sulfate CEP of the European Pharmacopoeia monograph is often referred to as a 1-Phenyl-2-aminopropane sulfate Certificate of Suitability (COS). The purpose of a 1-Phenyl-2-aminopropane sulfate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 1-Phenyl-2-aminopropane sulfate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 1-Phenyl-2-aminopropane sulfate to their clients by showing that a 1-Phenyl-2-aminopropane sulfate CEP has been issued for it. The manufacturer submits a 1-Phenyl-2-aminopropane sulfate CEP (COS) as part of the market authorization procedure, and it takes on the role of a 1-Phenyl-2-aminopropane sulfate CEP holder for the record. Additionally, the data presented in the 1-Phenyl-2-aminopropane sulfate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 1-Phenyl-2-aminopropane sulfate DMF.
A 1-Phenyl-2-aminopropane sulfate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 1-Phenyl-2-aminopropane sulfate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 1-Phenyl-2-aminopropane sulfate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 1-Phenyl-2-aminopropane sulfate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 1-Phenyl-2-aminopropane sulfate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 1-Phenyl-2-aminopropane sulfate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 1-Phenyl-2-aminopropane sulfate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 1-Phenyl-2-aminopropane sulfate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 1-Phenyl-2-aminopropane sulfate suppliers with NDC on PharmaCompass.
1-Phenyl-2-aminopropane sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 1-Phenyl-2-aminopropane sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 1-Phenyl-2-aminopropane sulfate GMP manufacturer or 1-Phenyl-2-aminopropane sulfate GMP API supplier for your needs.
A 1-Phenyl-2-aminopropane sulfate CoA (Certificate of Analysis) is a formal document that attests to 1-Phenyl-2-aminopropane sulfate's compliance with 1-Phenyl-2-aminopropane sulfate specifications and serves as a tool for batch-level quality control.
1-Phenyl-2-aminopropane sulfate CoA mostly includes findings from lab analyses of a specific batch. For each 1-Phenyl-2-aminopropane sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
1-Phenyl-2-aminopropane sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (1-Phenyl-2-aminopropane sulfate EP), 1-Phenyl-2-aminopropane sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (1-Phenyl-2-aminopropane sulfate USP).